Science

Is there actual clinical evidence that NAD+ boosters like NMN or NR can reverse cellular aging in humans?

🤖 AI reviewed 📅 Jun 2, 2026 👨‍⚕️ Expert reviewed ✍️ TryQuerra Editorial Team

Verdict

Limited evidence suggests NAD+ boosters like NMN or NR may have some anti-aging effects in humans.

Limited clinical evidence suggests that NAD+ boosters like Nicotinamide Mononucleotide (NMN) or Nicotinamide Riboside (NR) may have some potential anti-aging effects in humans.

Based on 8 reviewed sources including NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence - ScienceDirect, Recent research into nicotinamide mononucleotide and ageing, The Science Behind NMN–A Stable, Reliable NAD+Activator ....

Trust Score: 76%

8 sources reviewed

Updated Jun 2, 2026

Trust score breakdown ?

Source quality

76%

Source diversity

74%

Consensus strength

75%

Freshness

90%

Expert agreement

73%

Source agreement

100%

Score is an AI-weighted composite using 8 sources. Higher source agreement means fewer meaningful contradictions across reviewed sources. Learn how we calculate trust →

Full answer body

Expanded summary

Limited clinical evidence suggests that NAD+ boosters like Nicotinamide Mononucleotide (NMN) or Nicotinamide Riboside (NR) may have some potential anti-aging effects in humans. While studies have shown benefits such as improved energy metabolism and enhanced insulin sensitivity, definitive proof of their ability to reverse cellular aging in humans is still lacking. The evidence is mixed regarding the impact on metabolic, vascular, and cognitive outcomes. Clinical trials have not conclusively demonstrated significant anti-aging effects, although some studies suggest potential benefits in mitigating age-related changes.

Full analysis

Key Findings

Supporting Evidence

Studies have shown that NMN can mitigate various age-related changes, including improved energy metabolism and enhanced insulin sensitivity.
Animal models suggest that stimulating NAD+ with NMN or NR can extend healthspan and reduce premature aging.

Limitations and Caveats

Clinical trials have not conclusively demonstrated significant anti-aging effects in humans.
Evidence regarding the impact on metabolic, vascular, and cognitive outcomes is mixed.

Practical Implications

While NAD+ boosters like NMN or NR show promise in preclinical studies, more robust clinical trials are needed to establish their efficacy in reversing cellular aging in humans.

Evidence highlights

Studies have shown NMN can mitigate various age-related changes.
Animal models suggest NAD+ boosters can extend healthspan and reduce premature aging.
Clinical trials have not conclusively demonstrated significant anti-aging effects in humans.
Evidence on metabolic, vascular, and cognitive outcomes is mixed.